Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles: Therapeutics, Targets, and Development

Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways

Sabrina R. Perri, Daniel Martineau, Moïra François, Laurence Lejeune, Louis Bisson, Yves Durocher and Jacques Galipeau
Sabrina R. Perri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Martineau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moïra François
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Lejeune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis Bisson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Durocher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Galipeau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-06-0434 Published February 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2007 to January 2021

AbstractFull-text HTMLPDF
Total247420451330

Cited By

Article Information

Volume 6, Issue 2, pp. 441-449

DOI 
https://doi.org/10.1158/1535-7163.MCT-06-0434
PubMed 
17308045

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • December 21, 2006
  • July 25, 2006
  • October 2, 2006
  • Published first February 16, 2007.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Sabrina R. Perri1,
  2. Daniel Martineau2,
  3. Moïra François3,
  4. Laurence Lejeune3,
  5. Louis Bisson4,
  6. Yves Durocher4 and
  7. Jacques Galipeau135
  1. 1Division of Experimental Medicine, Lady Davis Institute for Medical Research, McGill University; 2Department of Pathology and Microbiology, Université de Montréal; 3Lady Davis Institute for Medical Research; 4Animal Cell Technology, Biotechnology Research Institute; and 5Division of Hematology/Oncology, Department of Medicine, Jewish General Hospital, Montreal, Quebec, Canada
  1. Requests for reprints: Jacques Galipeau, Lady Davis Institute for Medical Research, 3755 Cote-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2. Phone: 514-340-8214; Fax: 514-340-8281. E-mail: jacques.galipeau{at}mcgill.ca
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 6 (2)
February 2007
Volume 6, Issue 2
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways
Sabrina R. Perri, Daniel Martineau, Moïra François, Laurence Lejeune, Louis Bisson, Yves Durocher and Jacques Galipeau
Mol Cancer Ther February 1 2007 (6) (2) 441-449; DOI: 10.1158/1535-7163.MCT-06-0434

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways
Sabrina R. Perri, Daniel Martineau, Moïra François, Laurence Lejeune, Louis Bisson, Yves Durocher and Jacques Galipeau
Mol Cancer Ther February 1 2007 (6) (2) 441-449; DOI: 10.1158/1535-7163.MCT-06-0434
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy
  • Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
  • Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
Show more Research Articles: Therapeutics, Targets, and Development
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement